PHARMA : Departments : Drug Research Academy : Mini-symposia and lectures : Technical and Regulatory Challenges in Pharmaceutics
DRA Minisymposium: Technical and Regulatory Challenges in Pharmaceutics
<typohead type=4 align=left>Wednesday, October 27th 2004 in Auditorium 3</typohead>
The Danish University of Pharmaceutical Sciences, Universitetsparken 2, 2100 Copenhagen O
Program
| 9:00-9:10 | Introduction Sven Frokjaer, the Danish University of Pharmaceutical Sciences, Denmark |
| 9:10-11:40 | Central Regulatory Challenges in Pharmaceutics Chair: Kirsten Brønnum-Hansen |
| 9:10-9:50 | Dissolution Tests - a Tool in the Control of Product Quality Christina Graffner, Medical Products Agency, Sweden |
| 9:50-10:30 | A New Era in Biopharmaceutics: BCS Implication from Drug Discovery to Drug Product Regulation Gordon Amidon, University of Michigan, USA |
| 10:30-11:00 | Coffee Break |
| 11:00-11:40 | Promotion of Quality and Effectiveness of Medicines through the European Pharmacopoeia Derek H. Calam, British Pharmacopoeia Commission, UK |
| 12:00-13:00 | Lunch |
| 13:20-16:20 | Technical Challenges in Pharmaceutics Chair: Lars Hovgaard |
| 13:20-14:00 | The surface characterisation of amorphous material using inverse gas chromatography Graham Buckton, School of Pharmacy, University of London, UK |
| 14:00-14:40 | A Compaction Perspective on Particle Engineering Göran Alderborn, University of Uppsala, BMC, Sweden |
| 14:40-15:00 | Coffee Break |
| 15:00-15:40 | From Fundamental Agglomeration Studies to Practical Applications Torben Schæfer, the Danish University of Pharmaceutical Sciences, DK |
| 15:40-16:20 | Alternatives for Microcrystalline cellulose in Wet-extrusion/Spheronisation Peter Kleinbudde, Heinrich-Heine-Universität Düsseldorf, Germany |
| 17:00 | Reception |
The symposium is open for all interested. Participation is free of charge, however, for participation in the symposium including lunch please register before October 16, 2004, by e-mail to lej(at)dfuni.dk
The meeting is organised by: Kirsten Brønnum-Hansen (Danish Medicines Agency), Sven Frokjaer (the Danish University of Pharmaceutical Sciences), Lars Hovgaard (the Danish University of Pharmaceutical Sciences), and Torben Schæfer (the Danish University of Pharmaceutical Sciences).
